Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-01-03 @ 9:22 PM
Study NCT ID:
NCT03825367
Status:
UNKNOWN
Last Update Posted:
2022-10-12
First Post:
2019-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML
Sponsor:
Therapeutic Advances in Childhood Leukemia Consortium
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
T2016-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |